NCT03123835
Outcome Analysis of POEM and Endoluminal Therapies
Enrolling by Invitation
NAAges 18–80InterventionalTreatmentUniversity of California, DavisInvestigator-initiated
~500 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:Endoscopic Intervention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Decrease in GERDDQ
Measured over 3-6 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Mohamed R Ali, MD · PRINCIPAL_INVESTIGATOR · U.C. Davis Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult male and female patients 18-80 years of age
Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s)
Gastrointestinal Reflux Disease
Achalasia
Barrett's Esophagus
Post Bariatric Surgery conditions
Other gastrointestinal and postsurgical disorders.
Exclusion
Adults unable to consent
What this trial measures
- Decrease in GERDDQ3-6 months
Assessment will be made via post surgery questionnaire (decreasing in scoring will be 0-5)